Pistoia Alliance Calls on Life Science and Healthcare Ecosystems to Restructure Around Patient Centricity
Industry experts agree that patient centricity should be overriding aim of global life science R&D and healthcare ecosystems.
Members of the Pistoia Alliance, a global not-for-profit that advocates for greater collaboration in life sciences R&D, have called for the life science and healthcare industries urgently to restructure around patient centricity.
More than 150 attendees meeting at the Pistoia Alliance’s annual European conference in London agreed that the sector is undergoing a significant shift. In the wake of the global pandemic and driven by continual advances in technology, the voice of the empowered patient is on the rise. The Pistoia Alliance is now calling for greater collaboration between links in the biopharmaceutical value chain to support and advance this shift and ensure that patient centricity is embedded right from early discovery to healthcare delivery.
Read more about this announcement from the Pistoia Alliance here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
